Viewing Study NCT00317434


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2026-05-11 @ 3:36 AM
Study NCT ID: NCT00317434
Status: TERMINATED
Last Update Posted: 2009-12-15
First Post: 2006-04-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer
Sponsor: University of Alabama at Birmingham
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ovarian cancer View